Hepatitis C News

The prevalence of hepatitis C infections has declined globally, but countries must scale up rates of diagnosis and treatment to achieve the WHO targets to eliminate HCV by 2030, according to new data.

Healio spoke with Nancy S. Reau, MD, FAASLD, AGAF, about results from a study examining maternal and childhood outcomes of hepatitis C presented at The Liver Meeting Digital Experience.

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discussed one of the themes from The Liver Meeting Digital Experience: the effect of the COVID-19 pandemic on hepatitis C care.

Healio spoke with Nancy S. Reau, MD, FAASLD, AGAF, about a study evaluating a hepatitis C retreatment regimen in patients who failed therapy with Vosevi.

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discussed a study presented at The Liver Meeting Digital Experience demonstrating the effectiveness of a rapid treatment model in engaging people who inject drugs in treating their hepatitis C virus.

For patients with hepatitis C, universal screening and the integration of clinical pharmacists may improve access to direct-acting antiviral therapy and help patients achieve sustained virologic response, according to a poster presentation.

In patients with hepatitis C infection who failed treatment with Vosevi, retreatment with a regimen of Sovaldi plus Mavyret plus ribavirin for 16 to 24 weeks was safe and effective, researchers reported.

A simplified, rapid treatment model for hepatitis C virus improved cure rates and the cascade of care among young people who inject drugs, according to a recent study.

Patients with hepatitis C who achieved sustained virologic response through direct-acting antiviral therapy experienced a decrease in psychiatric hospitalizations after treatment, according to a presenter at The Liver Meeting Digital Experience.

In 2019, only 32% of children and youth who had tested positive for hepatitis C in British Columbia, Canada, had initiated treatment, according to data presented at The Liver Meeting Digital Experience.